BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Naltrexone

the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

298+ PubMed studies analyzed · 65 RCTs · Evidence Score: 55.7

Research Domains

Naltrexone has been studied across 18 research domains including 💊 Pain, 🫁 Liver & Detox, 🌤️ Mood & Depression, 😴 Sleep, 🔥 Metabolic. The primary research focus is 💊 Pain with 35% of studies addressing this area.

Loading evidence profile...

This evidence profile for Naltrexone is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.